Randomised clinical trial: Oral vs. intravenous iron after upper gastrointestinal haemorrhage - A placebo-controlled study

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 2, 2014, Pages 176-187

  Bager, P ^a   Dahlerup, J F ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FERROUS SULFATE; HEMOGLOBIN; PLACEBO;

ACUTE DISEASE; ADULT; AGED; ANEMIA; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION ROUTE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HOSPITAL DISCHARGE; HUMAN; HYPERPHOSPHATEMIA; INFUSION RELATED REACTION; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SKIN DISCOLORATION; TREATMENT DURATION; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84890485518     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12556     Document Type: Article

References (39)

1. Crooks CJ, West J, Card TR,. Upper gastrointestinal haemorrhage and deprivation: a nationwide cohort study of health inequality in hospital admissions. Gut 2012; 61: 514-20.
2. Gralnek IM, Barkun AN, Bardou M,. Management of acute bleeding from a peptic ulcer. N Engl J Med 2008; 359: 928-37.
3. Jairath V, Kahan BC, Logan RF, et al,. Mortality from acute upper gastrointestinal bleeding in the United Kingdom: does it display a "weekend effect"? Am J Gastroenterol 2011; 106: 1621-8.
4. Rockall TA, Logan RF, Devlin HB, Northfield TC,. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995; 311: 222-6.
5. van Leerdam ME, Vreeburg EM, Rauws EA, et al,. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98: 1494-9.
6. van Leerdam ME,. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 2008; 22: 209-24.
7. British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut 2002; 51 (Suppl. 4): iv1-6.
8. Barkun AN, Bardou M, Kuipers EJ, et al,. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010; 152: 101-13.
9. Palmer K, Nairn M,. Management of acute gastrointestinal blood loss: summary of SIGN guidelines. BMJ 2008; 337: a1832.
10. SIGN: Scottish Intercollegiate Guidelines Network. Management of Acute Upper and Lower Gastrointestinal Bleeding. A National Clinical Guideline. Edinburgh: The Network, 2008.
11. Villanueva C, Colomo A, Bosch A, et al,. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
12. Gordon S, Bensen S, Smith R,. Long-term follow-up of older patients with iron deficiency anemia after a negative GI evaluation. Am J Gastroenterol 1996; 91: 885-9.
13. Rockey DC, Cello JP,. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med 1993; 329: 1691-5.
14. Sahay R, Scott BB,. Iron deficiency anaemia-how far to investigate? Gut 1993; 34: 1427-8.
15. Schilling D, Grieger G, Weidmann E, Adamek HE, Benz C, Riemann JF,. Long-term follow-up of patients with iron deficiency anemia after a close endoscopic examination of the upper and lower gastrointestinal tract. Z Gastroenterol 2000; 38: 827-31.
16. Bager P, Dahlerup JF,. Lack of follow-up of anaemia after discharge from an upper gastrointestinal bleeding centre. Dan Med J 2013; 60: A4583.
17. Lewis JD, Bilker WB, Brensinger C, Farrar JR, Strom BL,. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol 2002; 97: 2540-9.
18. Yachimski PS, Friedman LS,. Gastrointestinal bleeding in the elderly. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 80-93.
19. Rockall TA, Logan RF, Devlin HB, Northfield TC,. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-21.
20. Khalafallah A, Dennis A, Bates J, et al,. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 2010; 268: 286-95.
21. Lachance K, Savoie M, Bernard M, et al,. Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother 2011; 45: 764-70.
22. Lindgren S, Wikman O, Befrits R, et al,. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009; 44: 838-45.
23. Haig A, Driman DK,. Iron-induced mucosal injury to the upper gastrointestinal tract. Histopathology 2006; 48: 808-12.
24. Kaye P, Abdulla K, Wood J, et al,. Iron-induced mucosal pathology of the upper gastrointestinal tract: a common finding in patients on oral iron therapy. Histopathology 2008; 53: 311-7.
25. Rimon E, Kagansky N, Kagansky M, et al,. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005; 118: 1142-7.
26. Ciacci C, Sabbatini F, Cavallaro R, et al,. Helicobacter pylori impairs iron absorption in infected individuals. Dig Liver Dis 2004; 36: 455-60.
27. Hershko C, Skikne B,. Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, helicobacter pylori, and autoimmune gastritis. Semin Hematol 2009; 46: 339-50.
28. McColl KE,. Effect of proton pump inhibitors on vitamins and iron. Am J Gastroenterol 2009; 104 (Suppl. 2): S5-9.
29. Lyseng-Williamson KA, Keating GM,. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 2009; 69: 739-56.
30. Erichsen K,. Iron therapy in inflammatory bowel disease: effects on oxidative stress and disease activity [MD dissertation]. Bergen: University of Bergen, 2005; 1-59.
31. Hurrell R, Egli I,. Iron bioavailability and dietary reference values. Am J Clin Nutr 2010; 91: 1461S-7S.
32. Gasche C, Lomer MC, Cavill I, Weiss G,. Iron, anaemia, and inflammatory bowel diseases. Gut 2004; 53: 1190-7.
33. WHO/UNICEF/UNU. Iron Deficiency Anemia: Assessment, Prevention and Control. Report of a joint WHO/UNICEF/UNU consultation. Geneva: World Health Organization, 1998.
34. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
35. Stein J, Hartmann F, Dignass AU,. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010; 7: 599-610.
36. Mani LY, Nseir G, Venetz JP, Pascual M,. Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient. Transplantation 2010; 90: 804-5.
37. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R,. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol 2008; 199: 435-7.
38. Hudson N, Faulkner G, Smith SJ, Langman MF, Hawkey CJ, Logan RF,. Late mortality in elderly patients surviving acute peptic ulcer bleeding. Gut 1995; 37: 177-81.
39. Ershler WB, Chen K, Reyes EB, Dubois R,. Economic burden of patients with anemia in selected diseases. Value Health 2005; 8: 629-38.